Late sodium current and calcium homeostasis in arrhythmogenesis

References

• Bers DM. Cardiac excitation-contraction coupling. Nature. 2002;415:198–205.
   PubMed Web of Science ®Google Scholar
• Eisner DA, Caldwell JL, Kistamas K, et al. Calcium and excitation-contraction coupling in the heart. Circ Res. 2017;121:181–195.
   PubMed Web of Science ®Google Scholar
• Kistamas K, Veress R, Horvath B, et al. Calcium handling defects and cardiac arrhythmia syndromes. Front Pharmacol. 2020;11:72.
   PubMed Web of Science ®Google Scholar
• Mitsuiye T, Noma A. Inactivation of cardiac Na+ channel simply through open states as revealed by single-channel analysis in guinea pig ventricular myocytes. Jpn J Physiol. 2002;52:457–469.
   PubMedGoogle Scholar
• Scanley BE, Hanck DA, Chay T, et al. Kinetic analysis of single sodium channels from canine cardiac Purkinje cells. J Gen Physiol. 1990;95:411–437.
   PubMed Web of Science ®Google Scholar
• Zaza A, Rocchetti M. The late Na+ current–origin and pathophysiological relevance. Cardiovasc Drugs Ther. 2013 ;27(1):61–68.
   PubMed Web of Science ®Google Scholar
• Sipido KR, Maes M, Van de Werf F. Low efficiency of Ca2+ entry through the Na(+)-Ca2+ exchanger as trigger for Ca2+ release from the sarcoplasmic reticulum. A comparison between L-type Ca2+ current and reverse-mode Na(+)-Ca2+ exchange. Circ Res. 1997;81:1034–1044.
   PubMed Web of Science ®Google Scholar
• Hodgkin AL, Huxley AF. A quantitative description of membrane current and its application to conduction and excitation in nerve. J Physiol. 1952;117:500–544.
   PubMed Web of Science ®Google Scholar
• Catterall WA, Goldin AL, Waxman SG. International union of pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels. Pharmacol Rev. 2005;57:397–409.
   PubMed Web of Science ®Google Scholar
• de Lera Ruiz M, Kraus RL. Voltage-gated sodium channels: structure, function, pharmacology, and clinical indications. J Med Chem. 2015;58:7093–7118.
   PubMed Web of Science ®Google Scholar
• Gellens ME, George AL Jr., Chen LQ, et al. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci U S A. 1992;89:554–558.
   PubMed Web of Science ®Google Scholar
• Maier SK, Westenbroek RE, Yamanushi TT, et al. An unexpected requirement for brain-type sodium channels for control of heart rate in the mouse sinoatrial node. Proc Natl Acad Sci U S A. 2003;100:3507–3512.
   PubMed Web of Science ®Google Scholar
• Maier SK, Westenbroek RE, Schenkman KA, et al. An unexpected role for brain-type sodium channels in coupling of cell surface depolarization to contraction in the heart. Proc Natl Acad Sci U S A. 2002;99:4073–4078.
   PubMed Web of Science ®Google Scholar
• Yang T, Atack TC, Stroud DM, et al. Blocking Scn10a channels in heart reduces late sodium current and is antiarrhythmic. Circ Res. 2012;111:322–332.
   PubMed Web of Science ®Google Scholar
• Biet M, Barajas-Martinez H, Ton AT, et al. About half of the late sodium current in cardiac myocytes from dog ventricle is due to non-cardiac-type Na(+) channels. J Mol Cell Cardiol. 2012;53:593–598.
   PubMed Web of Science ®Google Scholar
• Valdivia CR, Chu WW, Pu J, et al. Increased late sodium current in myocytes from a canine heart failure model and from failing human heart. J Mol Cell Cardiol. 2005;38:475–483.
   PubMed Web of Science ®Google Scholar
• Haufe V, Cordeiro JM, Zimmer T, et al. Contribution of neuronal sodium channels to the cardiac fast sodium current INa is greater in dog heart Purkinje fibers than in ventricles. Cardiovasc Res. 2005;65:117–127.
   PubMed Web of Science ®Google Scholar
• Maier LS, Sossalla S. The late Na current as a therapeutic target: where are we? J Mol Cell Cardiol. 2013;61:44–50.
   PubMed Web of Science ®Google Scholar
• Cusdin FS, Clare JJ, Jackson AP. Trafficking and cellular distribution of voltage-gated sodium channels. Traffic. 2008;9:17–26.
   PubMed Web of Science ®Google Scholar
• Brackenbury WJ, Isom LL. Na channel beta subunits: overachievers of the ion channel family. Front Pharmacol. 2011;2:53.
   PubMed Web of Science ®Google Scholar
• Kazen-Gillespie KA, Ragsdale DS, D’Andrea MR, et al. Cloning, localization, and functional expression of sodium channel beta1A subunits. J Biol Chem. 2000;275:1079–1088.
   PubMed Web of Science ®Google Scholar
• Qin N, D’Andrea MR, Lubin ML, et al. Molecular cloning and functional expression of the human sodium channel beta1B subunit, a novel splicing variant of the beta1 subunit. Eur J Biochem. 2003;270:4762–4770.
   PubMedGoogle Scholar
• Chen C, Cannon SC. Modulation of Na+ channel inactivation by the beta 1 subunit: a deletion analysis. Pflugers Arch. 1995;431:186–195.
   PubMed Web of Science ®Google Scholar
• Yu EJ, Ko SH, Lenkowski PW, et al. Distinct domains of the sodium channel beta3-subunit modulate channel-gating kinetics and subcellular location. Biochem J. 2005;392:519–526.
   PubMed Web of Science ®Google Scholar
• Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron. 2000;26:13–25.
   PubMed Web of Science ®Google Scholar
• Kellenberger S, Scheuer T, Catterall WA. Movement of the Na+ channel inactivation gate during inactivation. J Biol Chem. 1996;271:30971–30979.
   PubMed Web of Science ®Google Scholar
• West JW, Patton DE, Scheuer T, et al. A cluster of hydrophobic amino acid residues required for fast Na(+)-channel inactivation. Proc Natl Acad Sci U S A. 1992;89:10910–10914.
   PubMed Web of Science ®Google Scholar
• Patton DE, West JW, Catterall WA, et al. Amino acid residues required for fast Na(+)-channel inactivation: charge neutralizations and deletions in the III-IV linker. Proc Natl Acad Sci U S A. 1992;89:10905–10909.
   PubMed Web of Science ®Google Scholar
• Stuhmer W, Conti F, Suzuki H, et al. Structural parts involved in activation and inactivation of the sodium channel. Nature. 1989;339:597–603.
   PubMed Web of Science ®Google Scholar
• Motoike HK, Liu H, Glaaser IW, et al. The Na+ channel inactivation gate is a molecular complex: a novel role of the COOH-terminal domain. J Gen Physiol. 2004;123:155–165.
   PubMed Web of Science ®Google Scholar
• Armstrong CM. Na channel inactivation from open and closed states. Proc Natl Acad Sci U S A. 2006;103:17991–17996.
   PubMed Web of Science ®Google Scholar
• Kiyosue T, Arita M. Late sodium current and its contribution to action potential configuration in guinea pig ventricular myocytes. Circ Res. 1989;64:389–397.
   PubMed Web of Science ®Google Scholar
• Coraboeuf E, Deroubaix E, Coulombe A. Effect of tetrodotoxin on action potentials of the conducting system in the dog heart. A J Physiol. 1979;236:H561–7.
   PubMed Web of Science ®Google Scholar
• Maltsev VA, Sabbah HN, Higgins RS, et al. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation. 1998;98:2545–2552.
   PubMed Web of Science ®Google Scholar
• Zaniboni M, Pollard AE, Yang L, et al. Beat-to-beat repolarization variability in ventricular myocytes and its suppression by electrical coupling. Am J Physiol Heart Circ Physiol. 2000;278:H677–87.
   PubMed Web of Science ®Google Scholar
• Barandi L, Virag L, Jost N, et al. Reverse rate-dependent changes are determined by baseline action potential duration in mammalian and human ventricular preparations. Basic Res Cardiol. 2010;105:315–323.
   PubMed Web of Science ®Google Scholar
• Banyasz T, Horvath B, Virag L, et al. Reverse rate dependency is an intrinsic property of canine cardiac preparations. Cardiovasc Res. 2009;84:237–244.
   PubMed Web of Science ®Google Scholar
• Maltsev VA, Undrovinas AI. A multi-modal composition of the late Na+ current in human ventricular cardiomyocytes. Cardiovasc Res. 2006;69:116–127.
   PubMed Web of Science ®Google Scholar
• Mangold KE, Brumback BD, Angsutararux P, et al. Mechanisms and models of cardiac sodium channel inactivation. Channels (Austin). 2017;11:517–533.
   PubMed Web of Science ®Google Scholar
• Bers DM. Excitation-contraction coupling and cardiac contractile force. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2001.
   Google Scholar
• Liu H, Sun HY, Lau CP, et al. Regulation of voltage-gated cardiac sodium current by epidermal growth factor receptor kinase in guinea pig ventricular myocytes. J Mol Cell Cardiol. 2007;42:760–768.
   PubMed Web of Science ®Google Scholar
• Wang DW, Viswanathan PC, Balser JR, et al. Clinical, genetic, and biophysical characterization of SCN5A mutations associated with atrioventricular conduction block. Circulation. 2002;105:341–346.
   PubMed Web of Science ®Google Scholar
• Noble D, Noble PJ. Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload. Heart. 2006;92(Suppl 4):iv1–iv5.
   PubMedGoogle Scholar
• Horvath B, Hezso T, Szentandrassy N, et al. Late sodium current in human, canine and guinea pig ventricular myocardium. J Mol Cell Cardiol. 2020;139:14–23.
   PubMed Web of Science ®Google Scholar
• Horvath B, Banyasz T, Jian Z, et al. Dynamics of the late Na(+) current during cardiac action potential and its contribution to afterdepolarizations. J Mol Cell Cardiol. 2013;64:59–68.
   PubMed Web of Science ®Google Scholar
• Hegyi B, Bossuyt J, Griffiths LG, et al. Complex electrophysiological remodeling in postinfarction ischemic heart failure. Proc Natl Acad Sci U S A. 2018;115:E3036–E44.
   PubMed Web of Science ®Google Scholar
• Hegyi B, Banyasz T, Izu LT, et al. beta-adrenergic regulation of late Na(+) current during cardiac action potential is mediated by both PKA and CaMKII. J Mol Cell Cardiol. 2018;123:168–179.
   PubMed Web of Science ®Google Scholar
• Luo A, Ma J, Song Y, et al. Larger late sodium current density as well as greater sensitivities to ATX II and ranolazine in rabbit left atrial than left ventricular myocytes. Am J Physiol Heart Circ Physiol. 2014;306:H455–61.
   PubMed Web of Science ®Google Scholar
• Wu L, Ma J, Li H, et al. Late sodium current contributes to the reverse rate-dependent effect of IKr inhibition on ventricular repolarization. Circulation. 2011;123:1713–1720.
   PubMed Web of Science ®Google Scholar
• Nagatomo T, January CT, Ye B, et al. Rate-dependent QT shortening mechanism for the LQT3 deltaKPQ mutant. Cardiovasc Res. 2002;54:624–629.
   PubMed Web of Science ®Google Scholar
• Carmeliet E. Action potential duration, rate of stimulation, and intracellular sodium. J Cardiovasc Electrophysiol. 2006;17(Suppl 1):S2–S7.
   PubMedGoogle Scholar
• Szentandrassy N, Kistamas K, Hegyi B, et al. Contribution of ion currents to beat-to-beat variability of action potential duration in canine ventricular myocytes. Pflugers Arch. 2015;467:1431–1443.
   PubMed Web of Science ®Google Scholar
• Coppini R, Ferrantini C, Yao L, et al. Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation. 2013;127:575–584.
   PubMed Web of Science ®Google Scholar
• Song Y, Shryock JC, Belardinelli L. An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes. Am J Physiol Heart Circ Physiol. 2008;294:H2031–9.
   PubMed Web of Science ®Google Scholar
• Burashnikov A. Late INa inhibition as an antiarrhythmic strategy. J Cardiovasc Pharmacol. 2017;70:159–167.
   PubMed Web of Science ®Google Scholar
• Clancy CE, Tateyama M, Kass RS. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome. J Clin Invest. 2002;110:1251–1262.
   PubMed Web of Science ®Google Scholar
• Shryock JC, Song Y, Rajamani S, et al. The arrhythmogenic consequences of increasing late INa in the cardiomyocyte. Cardiovasc Res. 2013;99:600–611.
   PubMed Web of Science ®Google Scholar
• Undrovinas A, Maltsev VA. Late sodium current is a new therapeutic target to improve contractility and rhythm in failing heart. Cardiovasc Hematol Agents Med Chem. 2008;6:348–359.
   PubMedGoogle Scholar
• Pourrier M, Williams S, McAfee D, et al. CrossTalk proposal: the late sodium current is an important player in the development of diastolic heart failure (heart failure with a preserved ejection fraction). J Physiol. 2014;592:411–414.
   PubMed Web of Science ®Google Scholar
• Sossalla S, Wagner S, Rasenack EC, et al. Ranolazine improves diastolic dysfunction in isolated myocardium from failing human hearts–role of late sodium current and intracellular ion accumulation. J Mol Cell Cardiol. 2008;45:32–43.
   PubMed Web of Science ®Google Scholar
• Yao L, Fan P, Jiang Z, et al. Nav1.5-dependent persistent Na+ influx activates CaMKII in rat ventricular myocytes and N1325S mice. Am J Physiol Cell Physiol. 2011;301:C577–86.
   PubMed Web of Science ®Google Scholar
• Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63:2335–2345.
   PubMed Web of Science ®Google Scholar
• Zaza A, Belardinelli L, Shryock JC. Pathophysiology and pharmacology of the cardiac “late sodium current”. Pharmacol Ther. 2008;119:326–339.
   PubMed Web of Science ®Google Scholar
• Undrovinas AI, Fleidervish IA, Makielski JC. Inward sodium current at resting potentials in single cardiac myocytes induced by the ischemic metabolite lysophosphatidylcholine. Circ Res. 1992;71:1231–1241.
   PubMed Web of Science ®Google Scholar
• Tang Q, Ma J, Zhang P, et al. Persistent sodium current and Na+/H+ exchange contributes to the augmentation of the reverse Na+/Ca2+ exchange during hypoxia or acute ischemia in ventricular myocytes. Pflugers Arch. 2012;463:513–522.
   PubMed Web of Science ®Google Scholar
• Song Y, Shryock JC, Wagner S, et al. Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J Pharmacol Exp Ther. 2006;318:214–222.
   PubMed Web of Science ®Google Scholar
• Ma J, Song Y, Shryock JC, et al. Ranolazine attenuates hypoxia- and hydrogen peroxide-induced increases in sodium channel late openings in ventricular myocytes. J Cardiovasc Pharmacol. 2014;64:60–68.
   PubMed Web of Science ®Google Scholar
• Undrovinas AI, Maltsev VA, Sabbah HN. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci. 1999;55:494–505.
   PubMed Web of Science ®Google Scholar
• Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ Res. 2004;95:754–763.
   PubMed Web of Science ®Google Scholar
• Li W, Yu Y, Hou JW, et al. Larger rate dependence of late sodium current in cardiac Purkinje cells: A potential link to arrhythmogenesis. Heart Rhythm. 2017;14:422–431.
   PubMed Web of Science ®Google Scholar
• Sossalla S, Maurer U, Schotola H, et al. Diastolic dysfunction and arrhythmias caused by overexpression of CaMKIIdelta(C) can be reversed by inhibition of late Na(+) current. Basic Res Cardiol. 2011;106:263–272.
   PubMed Web of Science ®Google Scholar
• Liu T, O’Rourke B. Enhancing mitochondrial Ca2+ uptake in myocytes from failing hearts restores energy supply and demand matching. Circ Res. 2008;103:279–288.
   PubMed Web of Science ®Google Scholar
• Antzelevitch C, Nesterenko V, Shryock JC, et al. The role of late I Na in development of cardiac arrhythmias. Handb Exp Pharmacol. 2014;221:137–168.
   PubMedGoogle Scholar
• Wu L, Rajamani S, Li H, et al. Reduction of repolarization reserve unmasks the proarrhythmic role of endogenous late Na(+) current in the heart. Am J Physiol Heart Circ Physiol. 2009;297:H1048–57.
   PubMed Web of Science ®Google Scholar
• Song Y, Shryock JC, Wu L, et al. Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes. J Cardiovasc Pharmacol. 2004;44:192–199.
   PubMed Web of Science ®Google Scholar
• Murphy L, Renodin D, Antzelevitch C, et al. Extracellular proton depression of peak and late Na current in the canine left ventricle. Am J Physiol Heart Circ Physiol. 2011;301:H936–44.
   PubMed Web of Science ®Google Scholar
• Jones DK, Claydon TW, Ruben PC. Extracellular protons inhibit charge immobilization in the cardiac voltage-gated sodium channel. Biophys J. 2013;105:101–107.
   PubMed Web of Science ®Google Scholar
• Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev. 1999;79:917–1017.
   PubMed Web of Science ®Google Scholar
• Shimoda LA, Polak J. Hypoxia. 4. Hypoxia and ion channel function. Am J Physiol Cell Physiol. 2011;300:C951–67.
   PubMed Web of Science ®Google Scholar
• Ahern GP, Hsu SF, Klyachko VA, et al. Induction of persistent sodium current by exogenous and endogenous nitric oxide. J Biol Chem. 2000;275:28810–28815.
   PubMed Web of Science ®Google Scholar
• Yang P, Kupershmidt S, Roden DM. Cloning and initial characterization of the human cardiac sodium channel (SCN5A) promoter. Cardiovasc Res. 2004;61:56–65.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hartmann HA, Satin J. Glycosylation influences voltage-dependent gating of cardiac and skeletal muscle sodium channels. J Membr Biol. 1999;171:195–207.
   PubMed Web of Science ®Google Scholar
• Cortada E, Brugada R, Verges M. N-Glycosylation of the voltage-gated sodium channel beta2 subunit is required for efficient trafficking of NaV1.5/beta2 to the plasma membrane. J Biol Chem. 2019;294:16123–16140.
   PubMed Web of Science ®Google Scholar
• Sarhan MF, Van Petegem F, Ahern CA. A double tyrosine motif in the cardiac sodium channel domain III-IV linker couples calcium-dependent calmodulin binding to inactivation gating. J Biol Chem. 2009;284:33265–33274.
   PubMed Web of Science ®Google Scholar
• Beltran-Alvarez P, Pagans S, Brugada R. The cardiac sodium channel is post-translationally modified by arginine methylation. J Proteome Res. 2011;10:3712–3719.
   PubMed Web of Science ®Google Scholar
• Beyder A, Strege PR, Reyes S, et al. Ranolazine decreases mechanosensitivity of the voltage-gated sodium ion channel Na(v)1.5: a novel mechanism of drug action. Circulation. 2012;125:2698–2706.
   PubMed Web of Science ®Google Scholar
• Beyder A, Rae JL, Bernard C, et al. Mechanosensitivity of Nav1.5, a voltage-sensitive sodium channel. J Physiol. 2010;588:4969–4985.
   PubMed Web of Science ®Google Scholar
• Anderson ME. Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias. Pharmacol Ther. 2005;106:39–55.
   PubMed Web of Science ®Google Scholar
• Zhang T, Brown JH. Role of Ca2+/calmodulin-dependent protein kinase II in cardiac hypertrophy and heart failure. Cardiovasc Res. 2004;63:476–486.
   PubMed Web of Science ®Google Scholar
• Bers DM, Grandi E. Calcium/calmodulin-dependent kinase II regulation of cardiac ion channels. J Cardiovasc Pharmacol. 2009;54:180–187.
   PubMed Web of Science ®Google Scholar
• Maltsev VA, Reznikov V, Undrovinas NA, et al. Modulation of late sodium current by Ca2+, calmodulin, and CaMKII in normal and failing dog cardiomyocytes: similarities and differences. Am J Physiol Heart Circ Physiol. 2008;294:H1597–608.
   PubMed Web of Science ®Google Scholar
• Maltsev VA, Kyle JW, Undrovinas A. Late Na+ current produced by human cardiac Na+ channel isoform Nav1.5 is modulated by its beta1 subunit. J Physiol Sci. 2009;59: 217–225. .
   PubMed Web of Science ®Google Scholar
• Despa S, Bers DM. Na(+) transport in the normal and failing heart - remember the balance. J Mol Cell Cardiol. 2013;61:2–10.
   PubMed Web of Science ®Google Scholar
• Clancy CE, Chen-Izu Y, Bers DM, et al. Deranged sodium to sudden death. J Physiol. 2015;593:1331–1345.
   PubMed Web of Science ®Google Scholar
• Banyasz T, Horvath B, Jian Z, et al. Profile of L-type Ca(2+) current and Na(+)/Ca(2+) exchange current during cardiac action potential in ventricular myocytes. Heart Rhythm. 2012;9:134–142.
   PubMed Web of Science ®Google Scholar
• Banyasz T, Fulop L, Magyar J, et al. Endocardial versus epicardial differences in L-type calcium current in canine ventricular myocytes studied by action potential voltage clamp. Cardiovasc Res. 2003;58:66–75.
   PubMed Web of Science ®Google Scholar
• Fulop L, Banyasz T, Magyar J, et al. Reopening of L-type calcium channels in human ventricular myocytes during applied epicardial action potentials. Acta Physiol Scand. 2004;180:39–47.
   PubMedGoogle Scholar
• Linz KW, Meyer R. Profile and kinetics of L-type calcium current during the cardiac ventricular action potential compared in guinea-pigs, rats and rabbits. Pflugers Arch. 2000;439:588–599.
   PubMed Web of Science ®Google Scholar
• Linz KW, Meyer R. Control of L-type calcium current during the action potential of guinea-pig ventricular myocytes. J Physiol. 1998;513(Pt 2):425–442.
   PubMed Web of Science ®Google Scholar
• Maier LS. CaMKII regulation of voltage-gated sodium channels and cell excitability. Heart Rhythm. 2011;8:474–477.
   PubMed Web of Science ®Google Scholar
• Scheuer T. Regulation of sodium channel activity by phosphorylation. Semin Cell Dev Biol. 2011;22:160–165.
   PubMed Web of Science ®Google Scholar
• Tan HL, Kupershmidt S, Zhang R, et al. A calcium sensor in the sodium channel modulates cardiac excitability. Nature. 2002;415:442–447.
   PubMed Web of Science ®Google Scholar
• Wang DW, Makita N, Kitabatake A, et al. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome. Circ Res. 2000;87:E37–43.
   PubMed Web of Science ®Google Scholar
• Veldkamp MW, Viswanathan PC, Bezzina C, et al. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. Circ Res. 2000;86:E91–7.
   PubMed Web of Science ®Google Scholar
• Kim J, Ghosh S, Liu H, et al. Calmodulin mediates Ca2+ sensitivity of sodium channels. J Biol Chem. 2004;279:45004–45012.
   PubMed Web of Science ®Google Scholar
• Gardill BR, Rivera-Acevedo RE, Tung CC, et al. Crystal structures of Ca(2+)-calmodulin bound to NaV C-terminal regions suggest role for EF-hand domain in binding and inactivation. Proc Natl Acad Sci U S A. 2019;116:10763–10772.
   PubMed Web of Science ®Google Scholar
• Wang C, Chung BC, Yan H, et al. Structural analyses of Ca(2)(+)/CaM interaction with NaV channel C-termini reveal mechanisms of calcium-dependent regulation. Nat Commun. 2014;5:4896.
   PubMed Web of Science ®Google Scholar
• Wingo TL, Shah VN, Anderson ME, et al. An EF-hand in the sodium channel couples intracellular calcium to cardiac excitability. Nat Struct Mol Biol. 2004;11:219–225.
   PubMed Web of Science ®Google Scholar
• Wang C, Chung BC, Yan H, et al. Crystal structure of the ternary complex of a NaV C-terminal domain, a fibroblast growth factor homologous factor, and calmodulin. Structure. 2012;20:1167–1176.
   PubMed Web of Science ®Google Scholar
• Grandi E, Herren AW. CaMKII-dependent regulation of cardiac Na(+) homeostasis. Front Pharmacol. 2014;5:41.
   PubMed Web of Science ®Google Scholar
• Wagner S, Dybkova N, Rasenack EC, et al. Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J Clin Invest. 2006;116:3127–3138.
   PubMed Web of Science ®Google Scholar
• Hegyi B, Bers DM, Bossuyt J. CaMKII signaling in heart diseases: emerging role in diabetic cardiomyopathy. J Mol Cell Cardiol. 2019;127:246–259.
   PubMed Web of Science ®Google Scholar
• Liu N, Ruan Y, Denegri M, et al. Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C±) mice with catecholaminergic polymorphic ventricular tachycardia. J Mol Cell Cardiol. 2011;50:214–222.
   PubMed Web of Science ®Google Scholar
• Kashimura T, Briston SJ, Trafford AW, et al. In the RyR2(R4496C) mouse model of CPVT, beta-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves. Circ Res. 2010;107:1483–1489.
   PubMed Web of Science ®Google Scholar
• Venetucci L, Denegri M, Napolitano C, et al. Inherited calcium channelopathies in the pathophysiology of arrhythmias. Nat Rev Cardiol. 2012;9:561–575.
   PubMed Web of Science ®Google Scholar
• Guo T, Zhang T, Mestril R, et al. Ca2+/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes. Circ Res. 2006;99:398–406.
   PubMed Web of Science ®Google Scholar
• Maier LS, Zhang T, Chen L, et al. Transgenic CaMKIIdeltaC overexpression uniquely alters cardiac myocyte Ca2+ handling: reduced SR Ca2+ load and activated SR Ca2+ release. Circ Res. 2003;92:904–911.
   PubMed Web of Science ®Google Scholar
• Zhang T, Maier LS, Dalton ND, et al. The deltaC isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ Res. 2003;92:912–919.
   PubMed Web of Science ®Google Scholar
• Maier LS, Bers DM. Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc Res. 2007;73:631–640.
   PubMed Web of Science ®Google Scholar
• Ai X, Curran JW, Shannon TR, et al. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res. 2005;97:1314–1322.
   PubMed Web of Science ®Google Scholar
• Hoch B, Meyer R, Hetzer R, et al. Identification and expression of delta-isoforms of the multifunctional Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ Res. 1999;84:713–721.
   PubMed Web of Science ®Google Scholar
• Kirchhefer U, Schmitz W, Scholz H, et al. Activity of cAMP-dependent protein kinase and Ca2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc Res. 1999;42:254–261.
   PubMed Web of Science ®Google Scholar
• Kornyeyev D, El-Bizri N, Hirakawa R, et al. Contribution of the late sodium current to intracellular sodium and calcium overload in rabbit ventricular myocytes treated by anemone toxin. Am J Physiol Heart Circ Physiol. 2016;310:H426–35.
   PubMed Web of Science ®Google Scholar
• Wei XH, Yu SD, Ren L, et al. Inhibition of late sodium current suppresses calcium-related ventricular arrhythmias by reducing the phosphorylation of CaMK-II and sodium channel expressions. Sci Rep. 2017;7:981.
   PubMed Web of Science ®Google Scholar
• Smith GL, Eisner DA. Calcium buffering in the heart in health and disease. Circulation. 2019;139:2358–2371.
   PubMed Web of Science ®Google Scholar
• Eisner DA, Caldwell JL, Trafford AW, et al. The control of diastolic calcium in the heart: basic mechanisms and functional implications. Circ Res. 2020;126:395–412.
   PubMed Web of Science ®Google Scholar
• Boyman L, Williams GS, Khananshvili D, et al. NCLX: the mitochondrial sodium calcium exchanger. J Mol Cell Cardiol. 2013;59:205–213.
   PubMed Web of Science ®Google Scholar
• Kirichok Y, Krapivinsky G, Clapham DE. The mitochondrial calcium uniporter is a highly selective ion channel. Nature. 2004;427:360–364.
   PubMed Web of Science ®Google Scholar
• Ronchi C, Torre E, Rizzetto R, et al. Late sodium current and intracellular ionic homeostasis in acute ischemia. Basic Res Cardiol. 2017;112:12.
   PubMed Web of Science ®Google Scholar
• Mechmann S, Pott L. Identification of Na-Ca exchange current in single cardiac myocytes. Nature. 1986;319:597–599.
   PubMed Web of Science ®Google Scholar
• Kohlhaas M, Zhang T, Seidler T, et al. Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes. Circ Res. 2006;98:235–244.
   PubMed Web of Science ®Google Scholar
• Wu Y, Temple J, Zhang R, et al. Calmodulin kinase II and arrhythmias in a mouse model of cardiac hypertrophy. Circulation. 2002;106:1288–1293.
   PubMed Web of Science ®Google Scholar
• Volders PG, Kulcsar A, Vos MA, et al. Similarities between early and delayed afterdepolarizations induced by isoproterenol in canine ventricular myocytes. Cardiovasc Res. 1997;34:348–359.
   PubMed Web of Science ®Google Scholar
• Priori SG, Corr PB. Mechanisms underlying early and delayed afterdepolarizations induced by catecholamines. A J Physiol. 1990;258:H1796–805.
   PubMed Web of Science ®Google Scholar
• Szabo B, Sweidan R, Rajagopalan CV, et al. Role of Na+:Ca2+ exchange current in Cs(+)-induced early afterdepolarizations in Purkinje fibers. J Cardiovasc Electrophysiol. 1994;5:933–944.
   PubMed Web of Science ®Google Scholar
• Remme CA, Bezzina CR. Sodium channel (dys)function and cardiac arrhythmias. Cardiovasc Ther. 2010;28:287–294.
   PubMed Web of Science ®Google Scholar
• Belardinelli L, Giles WR, Rajamani S, et al. Cardiac late Na(+) current: proarrhythmic effects, roles in long QT syndromes, and pathological relationship to CaMKII and oxidative stress. Heart Rhythm. 2015;12:440–448.
   PubMed Web of Science ®Google Scholar
• Larbig R, Torres N, Bridge JH, et al. Activation of reverse Na+-Ca2+ exchange by the Na+ current augments the cardiac Ca2+ transient: evidence from NCX knockout mice. J Physiol. 2010;588:3267–3276.
   PubMed Web of Science ®Google Scholar
• Baartscheer A, Schumacher CA, Belterman CN, et al. [Na+]i and the driving force of the Na+/Ca2+-exchanger in heart failure. Cardiovasc Res. 2003;57:986–995.
   PubMed Web of Science ®Google Scholar
• Lindegger N, Hagen BM, Marks AR, et al. Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine. J Mol Cell Cardiol. 2009;47:326–334.
   PubMed Web of Science ®Google Scholar
• Fredj S, Lindegger N, Sampson KJ, et al. Altered Na+ channels promote pause-induced spontaneous diastolic activity in long QT syndrome type 3 myocytes. Circ Res. 2006;99:1225–1232.
   PubMed Web of Science ®Google Scholar
• Nanasi PP, Magyar J, Varro A, et al. Beat-to-beat variability of cardiac action potential duration: underlying mechanism and clinical implications. Can J Physiol Pharmacol. 2017;95:1230–1235.
   PubMed Web of Science ®Google Scholar
• Kistamas K, Szentandrassy N, Hegyi B, et al. Changes in intracellular calcium concentration influence beat-to-beat variability of action potential duration in canine ventricular myocytes. J Physiol Pharmacol. 2015;66:73–81.
   PubMed Web of Science ®Google Scholar
• Sarhan MF, Tung CC, Van Petegem F, et al. Crystallographic basis for calcium regulation of sodium channels. Proc Natl Acad Sci U S A. 2012;109:3558–3563.
   PubMed Web of Science ®Google Scholar
• Sag CM, Wadsack DP, Khabbazzadeh S, et al. Calcium/calmodulin-dependent protein kinase II contributes to cardiac arrhythmogenesis in heart failure. Circ Heart Fail. 2009;2:664–675.
   PubMed Web of Science ®Google Scholar
• Sossalla S, Kallmeyer B, Wagner S, et al. Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol. 2010;55:2330–2342.
   PubMed Web of Science ®Google Scholar
• Curran J, Brown KH, Santiago DJ, et al. Spontaneous Ca waves in ventricular myocytes from failing hearts depend on Ca(2+)-calmodulin-dependent protein kinase II. J Mol Cell Cardiol. 2010;49:25–32.
   PubMed Web of Science ®Google Scholar
• Anderson ME, Braun AP, Wu Y, et al. KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart. J Pharmacol Exp Ther. 1998;287:996–1006.
   PubMed Web of Science ®Google Scholar
• Yang Z, Kirton HM, Al-Owais M, et al. Epac2-rap1 signaling regulates reactive oxygen species production and susceptibility to cardiac arrhythmias. Antioxid Redox Signal. 2017;27:117–132.
   PubMed Web of Science ®Google Scholar
• Rokita AG, Anderson ME. New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII). Circulation. 2012;126:2125–2139.
   PubMed Web of Science ®Google Scholar
• Moreno JD, Zhu ZI, Yang PC, et al. A computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms. Sci Transl Med. 2011;3:98ra83.
   PubMed Web of Science ®Google Scholar
• Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med. 1991;324:781–788.
   PubMed Web of Science ®Google Scholar
• Horvath B, Hezso T, Kiss D, et al. Late sodium current inhibitors as potential antiarrhythmic agents. Front Pharmacol. 2020;11:413.
   PubMed Web of Science ®Google Scholar
• Pless SA, Galpin JD, Frankel A, et al. Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels. Nat Commun. 2011;2:351.
   PubMed Web of Science ®Google Scholar
• Carneiro JS, Bento AS, Bacic D, et al. The selective cardiac late sodium current inhibitor GS-458967 suppresses autonomically triggered atrial fibrillation in an intact porcine model. J Cardiovasc Electrophysiol. 2015;26:1364–1369.
   PubMed Web of Science ®Google Scholar
• Bonatti R, Silva AF, Batatinha JA, et al. Selective late sodium current blockade with GS-458967 markedly reduces ischemia-induced atrial and ventricular repolarization alternans and ECG heterogeneity. Heart Rhythm. 2014;11:1827–1835.
   PubMed Web of Science ®Google Scholar
• Pezhouman A, Madahian S, Stepanyan H, et al. Selective inhibition of late sodium current suppresses ventricular tachycardia and fibrillation in intact rat hearts. Heart Rhythm. 2014;11(3):492–501. .
   PubMed Web of Science ®Google Scholar
• Hasenfuss G, Maier LS. Mechanism of action of the new anti-ischemia drug ranolazine. Clin Res Cardiol. 2008;97:222–226.
   PubMed Web of Science ®Google Scholar
• Trenor B, Gomis-Tena J, Cardona K, et al. In silico assessment of drug safety in human heart applied to late sodium current blockers. Channels (Austin). 2013;7:249–262.
   PubMed Web of Science ®Google Scholar
• Bacic D, Carneiro JS, Bento AA, et al. Eleclazine, an inhibitor of the cardiac late sodium current, is superior to flecainide in suppressing catecholamine-induced ventricular tachycardia and T-wave alternans in an intact porcine model. Heart Rhythm. 2017;14:448–454.
   PubMed Web of Science ®Google Scholar
• Burton L, Knollan B. Goodman and Gilman’s the pharmacological basis of therapeutics. 12 ed. McGraw-Hill, NY, USA; 2010.
   Google Scholar
• Chaitman BR. Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions. Circulation. 2006;113:2462–2472.
   PubMed Web of Science ®Google Scholar
• Rajamani S, Shryock JC, Belardinelli L. Rapid kinetic interactions of ranolazine with HERG K+ current. J Cardiovasc Pharmacol. 2008;51:581–589.
   PubMed Web of Science ®Google Scholar
• Belardinelli L, Shryock JC, Fraser H. Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart. 2006;92(Suppl 4):iv6–iv14.
   PubMedGoogle Scholar
• Letienne R, Vie B, Puech A, et al. Evidence that ranolazine behaves as a weak beta1- and beta2-adrenoceptor antagonist in the rat [correction of cat] cardiovascular system. Naunyn-Schmiedeberg’s Arch Pharmacol. 2001;363:464–471.
   Google Scholar
• Doshi D, Morrow JP. Potential application of late sodium current blockade in the treatment of heart failure and atrial fibrillation. Rev Cardiovasc Med. 2009;10(Suppl 1):S46–52.
   PubMedGoogle Scholar
• Undrovinas AI, Belardinelli L, Undrovinas NA, et al. Ranolazine improves abnormal repolarization and contraction in left ventricular myocytes of dogs with heart failure by inhibiting late sodium current. J Cardiovasc Electrophysiol. 2006;17(Suppl 1):S169–S77.
   PubMedGoogle Scholar
• Zygmunt AC, Nesterenko VV, Rajamani S, et al. Mechanisms of atrial-selective block of Na(+) channels by ranolazine: I. Experimental analysis of the use-dependent block. Am J Physiol Heart Circ Physiol. 2011;301:H1606–14.
   PubMed Web of Science ®Google Scholar
• Szel T, Koncz I, Jost N, et al. Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations. Eur J Pharmacol. 2011;662:31–39.
   PubMed Web of Science ®Google Scholar
• Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation. 1997;96:2038–2047.
   PubMed Web of Science ®Google Scholar
• Belardinelli L, Liu G, Smith-Maxwell C, et al. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias. J Pharmacol Exp Ther. 2013;344:23–32.
   PubMed Web of Science ®Google Scholar
• Rajamani S, Liu G, El-Bizri N, et al. The novel late Na(+) current inhibitor, GS-6615 (eleclazine) and its anti-arrhythmic effects in rabbit isolated heart preparations. Br J Pharmacol. 2016;173:3088–3098.
   PubMed Web of Science ®Google Scholar
• Zygmunt AC, Eddlestone GT, Thomas GP, et al. Larger late sodium conductance in M cells contributes to electrical heterogeneity in canine ventricle. Am J Physiol Heart Circ Physiol. 2001;281:H689–97.
   PubMed Web of Science ®Google Scholar
• Baartscheer A, Schumacher CA, van Borren MM, et al. Increased Na+/H+-exchange activity is the cause of increased [Na+]i and underlies disturbed calcium handling in the rabbit pressure and volume overload heart failure model. Cardiovasc Res. 2003;57:1015–1024.
   PubMed Web of Science ®Google Scholar
• Moss AJ, Zareba W, Schwarz KQ, et al. Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome. J Cardiovasc Electrophysiol. 2008;19:1289–1293.
   PubMed Web of Science ®Google Scholar
• Wilson SR, Scirica BM, Braunwald E, et al. Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency with ranolazine for less ischemia in non-ST-segment elevation acute coronary syndromes) 36 Trial. J Am Coll Cardiol. 2009;53:1510–1516.
   PubMed Web of Science ®Google Scholar
• Hale SL, Leeka JA, Kloner RA. Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel. J Pharmacol Exp Ther. 2006;318:418–423.
   PubMed Web of Science ®Google Scholar
• Calderon-Sanchez EM, Dominguez-Rodriguez A, Lopez-Haldon J, et al. Cardioprotective effect of ranolazine in the process of ischemia-reperfusion in adult rat cardiomyocytes. Rev Esp Cardiologia. 2016;69:45–53.
   PubMed Web of Science ®Google Scholar
• Aldakkak M, Camara AK, Heisner JS, et al. Ranolazine reduces Ca2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts. Pharmacol Res. 2011;64:381–392.
   PubMed Web of Science ®Google Scholar
• Morita N, Lee JH, Xie Y, et al. Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine. J Am Coll Cardiol. 2011;57:366–375.
   PubMed Web of Science ®Google Scholar
• Hoyer K, Song Y, Wang D, et al. Reducing the late sodium current improves cardiac function during sodium pump inhibition by ouabain. J Pharmacol Exp Ther. 2011;337:513–523.
   PubMed Web of Science ®Google Scholar
• Jiang D, Shi H, Tonggu L, et al. Structure of the cardiac sodium channel. Cell. 2020;180:122–34 e10.
   PubMed Web of Science ®Google Scholar
• Hale SL, Shryock JC, Belardinelli L, et al. Late sodium current inhibition as a new cardioprotective approach. J Mol Cell Cardiol. 2008;44:954–967.
   PubMed Web of Science ®Google Scholar
• Sicouri S, Glass A, Belardinelli L, et al. Antiarrhythmic effects of ranolazine in canine pulmonary vein sleeve preparations. Heart Rhythm. 2008;5:1019–1026.
   PubMed Web of Science ®Google Scholar
• Gralinski MR, Black SC, Kilgore KS, et al. Cardioprotective effects of ranolazine (RS-43285) in the isolated perfused rabbit heart. Cardiovasc Res. 1994;28:1231–1237.
   PubMed Web of Science ®Google Scholar
• Haigney MC, Lakatta EG, Stern MD, et al. Sodium channel blockade reduces hypoxic sodium loading and sodium-dependent calcium loading. Circulation. 1994;90:391–399.
   PubMed Web of Science ®Google Scholar
• Antoons G, Oros A, Beekman JD, et al. Late na(+) current inhibition by ranolazine reduces torsades de pointes in the chronic atrioventricular block dog model. J Am Coll Cardiol. 2010;55:801–809.
   PubMed Web of Science ®Google Scholar
• Alves Bento AS, Bacic D, Saran Carneiro J, et al. Selective late INa inhibition by GS-458967 exerts parallel suppression of catecholamine-induced hemodynamically significant ventricular tachycardia and T-wave alternans in an intact porcine model. Heart Rhythm. 2015;12:2508–2514.
   PubMed Web of Science ®Google Scholar
• Antzelevitch C, Belardinelli L, Zygmunt AC, et al. Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties. Circulation. 2004;110:904–910.
   PubMed Web of Science ®Google Scholar
• Bossu A, Houtman MJC, Meijborg VMF, et al. Selective late sodium current inhibitor GS-458967 suppresses Torsades de Pointes by mostly affecting perpetuation but not initiation of the arrhythmia. Br J Pharmacol. 2018;175:2470–2482.
   PubMed Web of Science ®Google Scholar
• Sicouri S, Belardinelli L, Antzelevitch C. Antiarrhythmic effects of the highly selective late sodium channel current blocker GS-458967. Heart Rhythm. 2013;10:1036–1043.
   PubMed Web of Science ®Google Scholar
• Azam MA, Zamiri N, Masse S, et al. Effects of late sodium current blockade on ventricular refibrillation in a rabbit model. Circ Arrhythm Electrophysiol 2017; 10:e004331.
   Google Scholar
• Badri M, Patel A, Patel C, et al. Mexiletine prevents recurrent torsades de pointes in acquired long QT syndrome refractory to conventional measures. JACC Clin Electrophysiol. 2015;1:315–322.
   PubMedGoogle Scholar
• Frommeyer G, Garthmann J, Ellermann C, et al. Broad antiarrhythmic effect of mexiletine in different arrhythmia models. Europace. 2018;20:1375–1381.
   PubMed Web of Science ®Google Scholar
• Funasako M, Aiba T, Ishibashi K, et al. Pronounced shortening of QT interval with mexiletine infusion test in patients with type 3 congenital long QT syndrome. Circ J. 2016;80:340–345.
   PubMed Web of Science ®Google Scholar
• Bos JM, Crotti L, Rohatgi RK, et al. Mexiletine shortens the QT interval in patients with potassium channel-mediated type 2 long QT syndrome. Circ Arrhythm Electrophysiol. 2019;12:e007280.
   PubMed Web of Science ®Google Scholar
• Fujisawa T, Aizawa Y, Katsumata Y, et al. Mexiletine shortens the QT interval in a pedigree of KCNH2 related long QT syndrome. J Arrhythm. 2020;36:193–196.
   PubMed Web of Science ®Google Scholar
• Pignier C, Rougier JS, Vie B, et al. Selective inhibition of persistent sodium current by F 15845 prevents ischaemia-induced arrhythmias. Br J Pharmacol. 2010;161:79–91.
   PubMed Web of Science ®Google Scholar
• Vacher B, Pignier C, Letienne R, et al. 15845 inhibits persistent sodium current in the heart and prevents angina in animal models. Br J Pharmacol. 2009;156:214–225.
   PubMed Web of Science ®Google Scholar